Scholarlink

<p>Mild cognitive impairment (MCI) represents a prodromal stage of various neurodegenerative diseases. However, heterogeneity persists regarding heavy metal and trace element levels in MCI patients. PubMed, Web of Science, and Chinese academic databases were systematically searched from 2000 to the present, and 43 case-control/cross-sectional studies on the levels of heavy metals and trace elements in MCI and healthy controls were included, and the standardized mean difference (SMD) of 12 elements (Al, As, Cd, Pb, Cu, Se, Zn, etc.) was evaluated by using a random-effects model. A total of 16,743 samples were included. Al (SMD: 0.73, 95%CI: 0.31–1.14), As (SMD: 0.19, 95%CI: 0.03–0.35), Cd (SMD: 0.91, 95%CI: 0.43–1.38), Cu (SMD: 0.69, 95%CI. 0.27–1.10), Pb (SMD: 0.77, 95%CI: 0.30–1.24) were significantly elevated in the MCI patients, while Se (SMD: -0.28, 95%CI: -0.56-0.01) and Zn (SMD: -0.77, 95%CI: -1.22-0.33) were significantly lower. No statistical differences were observed for the remaining elements (Fe, Mg, etc.). Levels of specific heavy metals and trace elements in MCI patients differ from those in healthy controls. Monitoring and modulating these element levels may provide novel targets for early intervention strategies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Systematic Review and Meta-Analysis on Heavy Metals and Trace Elements in Mild Cognitive Impairment

  • 期刊论文

  • 发表日期：

    2025年12月26日

查看全文
  • Yaxin Dong,
  • Lu Ren,
  • TianRan Tang,
  • Xinyi Zhang,
  • Dan Han,
  • Yingyi Luo,
  • Liqiang Wang,
  • Zonghui Cui,
  • Sheng Ji,
  • Jianheng Zheng,
  • Ying Qing

摘要

Mild cognitive impairment (MCI) represents a prodromal stage of various neurodegenerative diseases. However, heterogeneity persists regarding heavy metal and trace element levels in MCI patients. PubMed, Web of Science, and Chinese academic databases were systematically searched from 2000 to the present, and 43 case-control/cross-sectional studies on the levels of heavy metals and trace elements in MCI and healthy controls were included, and the standardized mean difference (SMD) of 12 elements (Al, As, Cd, Pb, Cu, Se, Zn, etc.) was evaluated by using a random-effects model. A total of 16,743 samples were included. Al (SMD: 0.73, 95%CI: 0.31–1.14), As (SMD: 0.19, 95%CI: 0.03–0.35), Cd (SMD: 0.91, 95%CI: 0.43–1.38), Cu (SMD: 0.69, 95%CI. 0.27–1.10), Pb (SMD: 0.77, 95%CI: 0.30–1.24) were significantly elevated in the MCI patients, while Se (SMD: -0.28, 95%CI: -0.56-0.01) and Zn (SMD: -0.77, 95%CI: -1.22-0.33) were significantly lower. No statistical differences were observed for the remaining elements (Fe, Mg, etc.). Levels of specific heavy metals and trace elements in MCI patients differ from those in healthy controls. Monitoring and modulating these element levels may provide novel targets for early intervention strategies.